Cash and cash equivalents (USD, thousands)

Prepaid expenses and other current assets (USD, thousands)

Total current assets (USD, thousands)

Property and equipment, net (USD, thousands)

Intangible assets, net (USD, thousands)

Goodwill (USD, thousands)

Right-of-use assets (USD, thousands)

Other assets (USD, thousands)

Total assets (USD, thousands)

Accounts payable (USD, thousands)

Accrued expenses (USD, thousands)

Lease liability, current (USD, thousands)

Total current liabilities (USD, thousands)

Lease liability, non-current (USD, thousands)

Total liabilities (USD, thousands)

Preferred stock (USD, thousands)

Common stock (USD, thousands)

Additional paid-in capital (USD, thousands)

Accumulated other comprehensive income (loss) (USD, thousands)

Accumulated deficit (USD, thousands)

Total stockholders' equity (deficit) (USD, thousands)

Total liabilities and stockholders' equity (USD, thousands)

61ce0fe6a300af746e904819b990e1816f2b5df736b50fed404a84a755e77237

Product revenues (USD, thousands)

Total revenues (USD, thousands)

Research and development (USD, thousands)

General and administrative (USD, thousands)

Total cost and expenses (USD, thousands)

Loss from operations (USD, thousands)

Interest income, net (USD, thousands)

Total other income (USD, thousands)

Net loss (USD, thousands)

Comprehensive loss (USD, thousands)

Basic and diluted net loss per share (USD per share)

Weighted average shares used to compute net loss per common share — basic and diluted (shares)

5ccdccab05ee81ee343dc141e4776b2ed755b8f12be30b57fdf201afdbf7be63

Depreciation (USD, thousands)

Amortization of intangible assets (USD, thousands)

Stock-based compensation (USD, thousands)

Net cash used in operating activities (USD, thousands)

Purchases of property and equipment (USD, thousands)

Net cash used in investing activities (USD, thousands)

Proceeds from issuance of common stock under employee stock purchase plan (USD, thousands)

Proceeds from exercises of warrants (USD, thousands)

Proceeds from exercises of stock options (USD, thousands)

Net cash provided by financing activities (USD, thousands)

Net increase (decrease) in cash and cash equivalents (USD, thousands)

Supplemental disclosure: Equipment purchases included in accounts payable and accrued expenses (USD, thousands)

Cash and cash equivalents at beginning of period (USD, thousands)

Cash and cash equivalents at end of period (USD, thousands)

f187e8cb37c509eb57d5050197684a9cdd55cd2062cdda2661a1de1cafedb3f1

PULSE BIOSCIENCES (PLSE)

Financials